A1 Refereed original research article in a scientific journal

Salivary type I collagen degradation end-products and related matrix metalloproteinases in periodontitis.




AuthorsUlvi Kahraman Gursoy, Eija Könönen, Sisko Huumonen, Taina Tervahartiala, Pirkko J Pussinen, Anna L Suominen, Timo Sorsa

PublisherWiley-Blackwell Publishing, Inc.

Publication year2013

JournalJournal of Clinical Periodontology

Number in series1

Volume40

Issue1

First page 18

Last page25

Number of pages8

ISSN0303-6979

eISSN1600-051X

DOIhttps://doi.org/10.1111/jcpe.12020


Abstract
AIM:

Type I collagen degradation end-products and related matrix metalloproteinases (MMPs) were examined aiming to detect potential markers of periodontitis in saliva, with high sensitivity and specificity.


MATERIALS AND METHODS:

The salivary concentrations of MMP-8, MMP-9 and MMP-13, tartrate-resistant acid phosphatase serum type 5b, C-terminal cross-linked telopeptide of type I collagen (CTx), N-terminal cross-linked telopeptide of type I collagen (NTx) and cross-linked carboxyterminal telopeptide of type I collagen were analysed in 230 subjects. Oral health examination included panoramic radiography.


RESULTS:

The concentrations of MMP-8, MMP-9 and MMP-13 in saliva were higher in subjects with generalized periodontitis than in controls. Of the tested salivary markers, MMP-8 was the only marker capable of differentiating subjects with severe alveolar bone loss from those with slight bone loss (p < 0.001). The association between the salivary MMP-8 levels and periodontitis remained significant after the adjustment with age, gender and smoking. In addition, significant correlations were found between the tested markers and periodontal parameters.


CONCLUSION:

Enzymes and end-products of type I collagen degradation have different associations with each other and with periodontal status that may reflect their roles in the cascade leading to alveolar bone loss. MMP-8 is a strong biomarker candidate for detecting alveolar bone destruction.



Last updated on 2024-26-11 at 21:47